Ligand validation:6S3Z

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
6S3Z_NAG_A_1357	91%	47%	0.088	0.973	0.75	1.28	-	2	0	100%	0.9333
6S3Z_NAG_A_1444	90%	44%	0.075	0.958	1.17	0.99	2	1	0	100%	0.9333
6S3Z_NAG_B_1444	89%	44%	0.078	0.956	0.96	1.21	1	1	1	100%	0.9333
6S3Z_NAG_B_1471	80%	58%	0.092	0.941	0.53	1.07	-	1	0	100%	0.9333
6S3Z_NAG_A_1644	79%	35%	0.117	0.963	1.1	1.47	2	2	0	100%	0.9333
6S3Z_NAG_A_1471	77%	37%	0.093	0.933	0.76	1.68	-	3	3	100%	0.9333
6S3Z_NAG_B_1644	75%	25%	0.126	0.961	1.41	1.65	2	4	0	100%	0.9333
6S3Z_NAG_B_1357	63%	47%	0.146	0.943	0.77	1.28	-	2	0	100%	0.9333
6S3Z_NAG_B_1555	51%	49%	0.162	0.917	0.84	1.12	1	2	0	100%	0.9333
6S3Z_NAG_A_1236	47%	33%	0.165	0.905	1.21	1.45	1	3	0	100%	0.9333
6S3Z_NAG_A_1483	40%	53%	0.187	0.899	0.5	1.3	-	2	0	100%	0.9333
6S3Z_NAG_A_1555	29%	25%	0.18	0.838	0.98	2.03	1	5	0	100%	0.9333
6S3Z_NAG_B_1483	27%	47%	0.24	0.886	0.44	1.58	-	3	0	100%	0.9333
6S3Z_NAG_A_1539	17%	37%	0.249	0.825	0.94	1.51	-	1	0	100%	0.9333
6S3Z_NAG_A_1606	14%	40%	0.293	0.845	1.15	1.2	2	2	0	100%	0.9333
6S3Z_NAG_B_1539	14%	28%	0.273	0.821	1.29	1.61	2	1	1	100%	0.9333
6S3Z_NAG_A_1052	10%	38%	0.347	0.852	0.52	1.87	-	6	0	100%	0.9333
6S3Z_NAG_B_1052	9%	48%	0.344	0.841	0.39	1.59	-	5	0	100%	0.9333
6S3Z_NAG_A_1512	9%	32%	0.283	0.773	0.44	2.19	-	6	0	100%	0.9333
6S3Z_NAG_A_1242	6%	43%	0.387	0.821	0.41	1.78	-	4	0	100%	0.9333
6S3Z_NAG_A_1319	5%	32%	0.431	0.846	0.94	1.75	1	5	0	100%	0.9333
6S3Z_NAG_A_1215	4%	12%	0.385	0.747	1.07	3	2	5	0	100%	0.9333
6S3Z_NAG_B_1215	2%	35%	0.447	0.751	0.77	1.75	-	4	0	100%	0.9333
6S3Z_NAG_B_1242	2%	21%	0.507	0.764	0.79	2.47	-	6	0	100%	0.9333
6S3Z_NAG_A_1125	2%	25%	0.369	0.619	1.04	2	1	5	1	100%	0.9333
6S3Z_NAG_B_1319	1%	28%	0.475	0.661	0.56	2.27	-	3	0	100%	0.9333
5O47_NAG_B_1444	91%	65%	0.078	0.964	0.4	0.94	-	1	1	100%	0.9333
6S82_NAG_A_1444	91%	48%	0.084	0.969	0.89	1.13	-	2	0	100%	0.9333
5ANN_NAG_B_1471	89%	60%	0.084	0.962	0.56	0.97	-	1	0	100%	0.9333
5FK7_NAG_A_1471	88%	56%	0.079	0.955	0.29	1.36	-	4	1	100%	0.9333
5FK8_NAG_A_1471	87%	57%	0.079	0.952	0.33	1.29	-	2	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.

Prepare Data

Validate Data

Deposit Data

Help and Resources

6S3Z

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose